Skip to main content
Esc

Type to search

Articles / institutional-equities / OpenEvidence Brings Hands-Free Medical AI to 860,000 Clinicians

OpenEvidence Brings Hands-Free Medical AI to 860,000 Clinicians

Clinician Users
860,000
Number of licensed U.S. clinicians using OpenEvidence's platform
Daily Clinical Questions
1 million
Number of clinical questions fielded daily by OpenEvidence's platform
Series D Funding
$250 million
Amount raised in the Series D funding round in January

⦿ Executive Snapshot

  • What: OpenEvidence launches Voice Mode, a hands-free AI-powered medical search feature for clinicians.
  • Who: OpenEvidence, Cedars-Sinai, Mount Sinai, Sutter Health, Ania Bilski, Daniel Nadler.
  • Why it matters: This innovation aims to enhance clinical efficiency and reduce interruptions in high-volume medical environments.

⦿ Key Developments

  • OpenEvidence's Voice Mode feature allows clinicians to ask clinical questions and receive spoken answers without touching a screen.
  • The platform is currently used by 860,000 licensed U.S. clinicians and fields over 1 million clinical questions per day.
  • OpenEvidence raised $250 million in a Series D funding round in January, achieving a $12 billion valuation.

⦿ Strategic Context

  • The clinical AI market is increasingly competitive, with major players like Microsoft introducing similar voice dictation technologies.
  • OpenEvidence's integration with EHR workflows aligns with the growing trend of AI adoption in healthcare to alleviate clinician burnout and streamline operations.

⦿ Strategic Implications

  • The immediate consequence of the Voice Mode launch is enhanced operational efficiency for clinicians, potentially reducing burnout and improving patient care.
  • Long-term, OpenEvidence's integration into EHR systems positions it as a crucial tool in the evolving landscape of healthcare technology.

⦿ Risks & Constraints

  • Integration challenges with existing healthcare systems and fragmented data could hinder broader adoption of the Voice Mode feature.
  • The competitive landscape may pressure OpenEvidence to continuously innovate and differentiate its offerings from similar products.

⦿ Watchlist / Forward Signals

  • Upcoming milestones include the development of a non-ad-supported enterprise pricing tier for large healthcare systems.
  • Monitoring user feedback from the new health system partnerships will provide insights into the effectiveness and adoption of Voice Mode in clinical settings.
§ 08

Related Articles